Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium

BACKGROUND: Erythropoietin possesses cellular protection properties. The aim of the present study was to test the hypothesis that in situ expression of recombinant human erythropoietin (rhEPO) would improve tissue repair in rat after myocardial infarction (MI). METHODS AND RESULTS: RhEPO-producing c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ruvinov, Emil, Sharabani-Yosef, Orna, Nagler, Arnon, Einbinder, Tom, Feinberg, Micha S, Holbova, Radka, Douvdevani, Amos, Leor, Jonathan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2008
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2585557/
https://ncbi.nlm.nih.gov/pubmed/19014419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-1536-1-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller